| HCV | Aβ42 | Aβ40 | p-Tau | t-Tau | MMSE | CDR-sb | CERAD-DR | Aβ42/Aβ40 |
---|
HCV | | ns |
0.03
| ns | ns | ns | ns | ns | ns |
Aβ42 | | | ns | ns | ns | ns | ns | ns | ns |
Aβ40 | | | |
0.02
|
0.00
|
0.04
|
0.02
|
0.05
| 0.06 |
p-Tau | | | | |
0.03
| ns | ns | ns | ns |
t-Tau | | | | | | ns | ns | ns |
0.02
|
MMSE | | | | | | | ns | ns | ns |
CDR-sb | | | | | | | | ns | ns |
CERAD-DR | | | | | | | | | ns |
- Significant values are shown in bold typeface
- Data were not corrected for multiple testing
- For comparing areas under the curve we used a bootstrapping algorithm as implemented in pROC packages (Version 1.8)
-
Aβ40 amyloid-beta1–40, Aβ42 amyloid-beta1–42, CDR-sb Clinical Dementia Rating–sum-of-boxes, CERAD-DR Consortium to Establish a Registry of Dementia–delayed recall, HCV hippocampal volume, MMSE Mini-Mental State Examination, ns not significant, p-Tau phosphorylated tau, t-Tau total tau